Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision Oncology: Between Vaguely Right and Precisely Wrong
Amy Brock, Sui Huang
Cancer Research (2017) Vol. 77, Iss. 23, pp. 6473-6479
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity
Mohit Kumar Jolly, Prakash Kulkarni, Keith Weninger, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 138
Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, et al.
PLoS Computational Biology (2019) Vol. 15, Iss. 3, pp. e1006658-e1006658
Open Access | Times Cited: 119
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways
Xue Bai, David E. Fisher, Keith T. Flaherty
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 9, pp. 549-562
Open Access | Times Cited: 85
Optimizing Precision Medicine for Public Health
Gemma A. Bilkey, Belinda L. Burns, Emily P. Coles, et al.
Frontiers in Public Health (2019) Vol. 7
Open Access | Times Cited: 79
Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring
Claire E. Knezevic, William Clarke
Therapeutic Drug Monitoring (2019) Vol. 42, Iss. 1, pp. 6-19
Closed Access | Times Cited: 78
Over a century of cancer research: Inconvenient truths and promising leads
Carlos Sonnenschein, Ana M. Soto
PLoS Biology (2020) Vol. 18, Iss. 4, pp. e3000670-e3000670
Open Access | Times Cited: 78
Polyploidy as a Fundamental Phenomenon in Evolution, Development, Adaptation and Diseases
Olga V. Anatskaya, Alexander E. Vinogradov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3542-3542
Open Access | Times Cited: 52
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board
Kathrin Heinrich, Lisa Miller‐Phillips, Frank Ziemann, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 1905-1915
Open Access | Times Cited: 40
Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability
Nicola Fusco, Gianluca Lopez, Chiara Corti, et al.
JNCI Cancer Spectrum (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 75
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
Dirk Schumacher, Geoffroy Andrieux, Karsten Boehnke, et al.
PLoS Genetics (2019) Vol. 15, Iss. 3, pp. e1008076-e1008076
Open Access | Times Cited: 71
Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
Francesca Finotello, Federica Eduati
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 69
Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases
Thomas Litman
Apmis (2019) Vol. 127, Iss. 5, pp. 386-424
Open Access | Times Cited: 64
Drug repurposing for cancer therapy, easier said than done
Aurora González‐Fierro, Alfonso Dueñas‐González
Seminars in Cancer Biology (2019) Vol. 68, pp. 123-131
Closed Access | Times Cited: 55
Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer
Sui Huang
Trends in cancer (2021) Vol. 7, Iss. 4, pp. 309-322
Closed Access | Times Cited: 55
Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer
Lakshya Chauhan, Uday Ram, Kishore Hari, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 55
Precision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
Ulrike Pfohl, Alina Pflaume, Manuela Regenbrecht, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 928-928
Open Access | Times Cited: 44
Precision Oncology: a Clinical and Patient Perspective
Ulrik Lassen, Lydia Makaroff, Albrecht Stenzinger, et al.
Future Oncology (2021) Vol. 17, Iss. 30, pp. 3995-4009
Open Access | Times Cited: 41
The end of the genetic paradigm of cancer
Sui Huang, Ana M. Soto, Carlos Sonnenschein
PLoS Biology (2025) Vol. 23, Iss. 3, pp. e3003052-e3003052
Open Access
Guilu Erxian Glue Alleviates Chemotherapy-induced Myelosuppression by Regulating Histone Methylation Level of p16 gene in Hematopoietic Stem Cells
Menglei Wang, J W Wang, Weizhi Lai, et al.
Deleted Journal (2025), pp. 200213-200213
Open Access
PAGE4 and Conformational Switching: Insights from Molecular Dynamics Simulations and Implications for Prostate Cancer
Xingcheng Lin, Susmita Roy, Mohit Kumar Jolly, et al.
Journal of Molecular Biology (2018) Vol. 430, Iss. 16, pp. 2422-2438
Open Access | Times Cited: 39
Functionalizing tetrahedral framework nucleic acids-based nanostructures for tumor in situ imaging and treatment
Minghui Hu, Yingyu Zhang, Mengxin Zhang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 240, pp. 113982-113982
Closed Access | Times Cited: 4
Natural Kinds as Homeorhetic Dynamic Systems
Davide Serpico, Francesco Guala
The British Journal for the Philosophy of Science (2025)
Closed Access
A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
Grant Howard, Kaitlyn E. Johnson, Areli Rodriguez Ayala, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Multiplexed Gene Expression Tuning with Orthogonal Synthetic Gene Circuits
Mariola Szenk, Terrence Yim, Gábor Balázsi
ACS Synthetic Biology (2020) Vol. 9, Iss. 4, pp. 930-939
Open Access | Times Cited: 31
Human Molecular Genetics Has Not Yet Contributed to Measurable Public Health Advances
Nigel Paneth, Sten H. Vermund
Perspectives in biology and medicine (2018) Vol. 61, Iss. 4, pp. 537-549
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top